166 results
Page 2 of 9
8-K
EX-1.1
5vebygatp
28 May 21
Other Events
5:11pm
8-K
EX-1.1
xgtyajm0tp6 i5et
26 Mar 21
Other Events
4:06pm
424B5
im34s
24 Mar 21
Prospectus supplement for primary offering
4:01pm
424B5
lih4s3j6
23 Mar 21
Prospectus supplement for primary offering
5:13pm
8-K
EX-99.1
nxljv
1 Feb 21
Prothena Announces Confirmatory Phase 3 AFFIRM-AL Study of Birtamimab in Mayo Stage IV Patients with AL Amyloidosis under SPA Agreement with FDA
4:16pm
SC TO-I/A
EX-99
l0cbls4
28 Jan 21
Issuer tender offer statement (amended)
5:02pm
SC TO-I/A
EX-99
bq7g0ox1ja1cl 1wi70
28 Jan 21
Issuer tender offer statement (amended)
5:02pm
SC TO-I/A
EX-99
hfv1kd
28 Jan 21
Issuer tender offer statement (amended)
5:02pm
SC TO-I/A
EX-99
umhn0bpt
21 Jan 21
Issuer tender offer statement (amended)
5:01pm
8-K
EX-99.1
2s7p4cmq1k
9 Dec 20
Other Events
8:03am